Posted by admin on Jun 7th, 2022

DENTSPLY SIRONA (NASDAQ:XRAY – Get Rating) issued an update on its FY 2022 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of $2.35-$2.55 for the period, compared to the consensus estimate of $2.77. The company issued revenue guidance of $4.10 billion-$4.20 billion, compared to the consensus revenue estimate of $4.23 billion.

Shares of XRAY stock opened at $40.43 on Tuesday. DENTSPLY SIRONA has a 52-week low of $35.00 and a 52-week high of $66.98. The company has a quick ratio of 1.03, a current ratio of 1.45 and a debt-to-equity ratio of 0.38. The stock has a market cap of $8.71 billion, a PE ratio of 23.92 and a beta of 0.94. The business has a 50-day simple moving average of $42.42 and a 200-day simple moving average of $49.25.

DENTSPLY SIRONA (NASDAQ:XRAY – Get Rating) last announced its quarterly earnings results on Tuesday, May 10th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.50 by $0.02. The company had revenue of $9.67 billion during the quarter, compared to the consensus estimate of $982.05 million. DENTSPLY SIRONA had a return on equity of 11.63% and a net margin of 8.81%. DENTSPLY SIRONA’s revenue for the quarter was up 841.1% on a year-over-year basis. During the same period in the previous year, the company posted $0.72 earnings per share. Sell-side analysts anticipate that DENTSPLY SIRONA will post 2.42 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 8th. Shareholders of record on Friday, June 24th will be issued a $0.125 dividend. The ex-dividend date is Thursday, June 23rd. This represents a $0.50 dividend on an annualized basis and a yield of 1.24%. DENTSPLY SIRONA’s payout ratio is 29.59%.

XRAY has been the subject of a number of research analyst reports. Robert W. Baird cut shares of DENTSPLY SIRONA from an outperform rating to a neutral rating and reduced their price objective for the stock from $67.00 to $48.00 in a research report on Tuesday, April 19th. StockNews.com cut DENTSPLY SIRONA from a buy rating to a hold rating in a report on Thursday, May 26th. Morgan Stanley lowered their price target on DENTSPLY SIRONA from $62.00 to $52.00 and set an overweight rating on the stock in a research note on Wednesday, April 20th. HC Wainwright reduced their price objective on DENTSPLY SIRONA from $58.00 to $48.00 and set a hold rating for the company in a research note on Friday, April 22nd. Finally, William Blair cut shares of DENTSPLY SIRONA from an outperform rating to a market perform rating in a research report on Tuesday, April 19th. Seven research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of Hold and a consensus price target of $52.30.

In other DENTSPLY SIRONA news, Director Eric Brandt sold 6,900 shares of the firm’s stock in a transaction on Tuesday, May 3rd. The stock was sold at an average price of $39.71, for a total transaction of $273,999.00. Following the completion of the sale, the director now owns 35,155 shares of the company’s stock, valued at $1,396,005.05. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 0.76% of the stock is owned by company insiders.

Several institutional investors and hedge funds have recently made changes to their positions in the business. The Manufacturers Life Insurance Company lifted its stake in DENTSPLY SIRONA by 61.4% during the first quarter. The Manufacturers Life Insurance Company now owns 268,365 shares of the medical instruments supplier’s stock worth $13,209,000 after purchasing an additional 102,134 shares in the last quarter. Toroso Investments LLC boosted its holdings in DENTSPLY SIRONA by 12.9% during the 1st quarter. Toroso Investments LLC now owns 9,175 shares of the medical instruments supplier’s stock valued at $452,000 after acquiring an additional 1,050 shares during the period. Worldquant Millennium Advisors LLC acquired a new position in DENTSPLY SIRONA in the 1st quarter valued at about $12,912,000. KB Financial Partners LLC increased its stake in DENTSPLY SIRONA by 19.5% during the first quarter. KB Financial Partners LLC now owns 4,443 shares of the medical instruments supplier’s stock worth $219,000 after purchasing an additional 726 shares during the period. Finally, SkyView Investment Advisors LLC lifted its position in shares of DENTSPLY SIRONA by 17.0% during the first quarter. SkyView Investment Advisors LLC now owns 4,878 shares of the medical instruments supplier’s stock worth $240,000 after purchasing an additional 710 shares in the last quarter. Institutional investors and hedge funds own 94.79% of the company’s stock.

DENTSPLY SIRONA Company Profile (Get Rating)

DENTSPLY SIRONA Inc designs, develops, manufactures, distributes, and sells various dental products and technologies for professional dental market worldwide. It offers dental equipment, including treatment centers, imaging equipment, motorized dental handpieces, and other instruments; imaging equipment; treatment centers comprising basic dentist chairs, sophisticated chair-based units with integrated diagnostic, hygiene and ergonomic functionalities, and specialist centers; and lab equipment, such as amalgamators, mixing machines, and porcelain furnaces.

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.

Zacks Investment Research Increases Cedar Fair (NYSE:FUN) Price Target to $70.50

Wishpond Technologies (OTCMKTS:WPNDF) Coverage Initiated at Canaccord Genuity Group